https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 The role of truncated p53 isoforms in the DNA damage response https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53018 Wed 28 Feb 2024 16:09:22 AEDT ]]> GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47696 Wed 25 Jan 2023 08:57:08 AEDT ]]> DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48767 Wed 05 Apr 2023 13:55:36 AEST ]]> Cancer therapies inducing DNA damage https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49650 Thu 25 May 2023 14:37:48 AEST ]]> ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54816 Thu 14 Mar 2024 14:38:44 AEDT ]]> Ovarian ageing: where are we now? And where to next? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46268 Mon 14 Nov 2022 15:06:53 AEDT ]]> Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51740 Fri 15 Sep 2023 18:14:17 AEST ]]>